BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Textoris J, Ivorra D, Ben Amara A, Sabatier F, Ménard JP, Heckenroth H, Bretelle F, Mege JL. Evaluation of current and new biomarkers in severe preeclampsia: a microarray approach reveals the VSIG4 gene as a potential blood biomarker. PLoS One 2013;8:e82638. [PMID: 24349325 DOI: 10.1371/journal.pone.0082638] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 D'angelo A, Valsecchi L. High dose antithrombin supplementation in early preeclampsia: A randomized, double blind, placebo-controlled study. Thrombosis Research 2016;140:7-13. [DOI: 10.1016/j.thromres.2016.01.024] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
2 Alur V, Raju V, Vastrad B, Tengli A, Vastrad C, Kotturshetti S. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gestational diabetes mellitus. Biosci Rep 2021;41:BSR20210617. [PMID: 33890634 DOI: 10.1042/BSR20210617] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wang T, Shi XZ, Wu WH. Crosstalk analysis of dysregulated pathways in preeclampsia. Exp Ther Med 2019;17:2298-304. [PMID: 30867714 DOI: 10.3892/etm.2019.7178] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Mezouar S, Mege J. Gene Expression Profiling of Placenta from Normal to Pathological Pregnancies. In: R. G. A, editor. Placenta. IntechOpen; 2018. [DOI: 10.5772/intechopen.80551] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
5 Hahn S, Lapaire O, Than NG. Biomarker development for presymptomatic molecular diagnosis of preeclampsia: feasible, useful or even unnecessary? Expert Rev Mol Diagn 2015;15:617-29. [PMID: 25774007 DOI: 10.1586/14737159.2015.1025757] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
6 Zhou W, Zhang K, Chen D, Gao P, Wang Q. Gene microarray analyses for potential biomarkers of single and recurrent venous thromboembolism. Mol Med Rep. 2015;12:7358-7366. [PMID: 26397997 DOI: 10.3892/mmr.2015.4349] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
7 Eidem HR, Ackerman WE 4th, McGary KL, Abbot P, Rokas A. Gestational tissue transcriptomics in term and preterm human pregnancies: a systematic review and meta-analysis. BMC Med Genomics 2015;8:27. [PMID: 26044726 DOI: 10.1186/s12920-015-0099-8] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 5.0] [Reference Citation Analysis]
8 Kelliher S, Maguire PB, Szklanna PB, Weiss L, Ewins K, O'Doherty R, Angelov D, Ní Áinle F, Kevane B. Pathophysiology of the Venous Thromboembolism Risk in Preeclampsia. Hamostaseologie 2020;40:594-604. [PMID: 32450576 DOI: 10.1055/a-1162-3905] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Oshchepkov D, Chadaeva I, Kozhemyakina R, Zolotareva K, Khandaev B, Sharypova E, Ponomarenko P, Bogomolov A, Klimova NV, Shikhevich S, Redina O, Kolosova NG, Nazarenko M, Kolchanov NA, Markel A, Ponomarenko M. Stress Reactivity, Susceptibility to Hypertension, and Differential Expression of Genes in Hypertensive Compared to Normotensive Patients. Int J Mol Sci 2022;23:2835. [PMID: 35269977 DOI: 10.3390/ijms23052835] [Reference Citation Analysis]
10 Guo F, Zhang B, Yang H, Fu Y, Wang Y, Huang J, Cheng M, Li X, Shen Z, Li L, He P, Xiang AP, Wang S, Zhang H. Systemic transcriptome comparison between early- And late-onset pre-eclampsia shows distinct pathology and novel biomarkers. Cell Prolif 2021;54:e12968. [PMID: 33332660 DOI: 10.1111/cpr.12968] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Chaussabel D. Assessment of immune status using blood transcriptomics and potential implications for global health. Semin Immunol 2015;27:58-66. [PMID: 25823891 DOI: 10.1016/j.smim.2015.03.002] [Cited by in Crossref: 58] [Cited by in F6Publishing: 43] [Article Influence: 8.3] [Reference Citation Analysis]
12 Tarca AL, Romero R, Erez O, Gudicha DW, Than NG, Benshalom-Tirosh N, Pacora P, Hsu CD, Chaiworapongsa T, Hassan SS, Gomez-Lopez N. Maternal whole blood mRNA signatures identify women at risk of early preeclampsia: a longitudinal study. J Matern Fetal Neonatal Med 2020;:1-12. [PMID: 31900005 DOI: 10.1080/14767058.2019.1685964] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
13 Currie G, Delles C. The Future of "Omics" in Hypertension. Can J Cardiol 2017;33:601-10. [PMID: 28161100 DOI: 10.1016/j.cjca.2016.11.023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
14 Lin J, Meng Y, Song M, Gu W. Network-Based Analysis Reveals Novel Biomarkers in Peripheral Blood of Patients With Preeclampsia. Front Mol Biosci 2022;9:757203. [DOI: 10.3389/fmolb.2022.757203] [Reference Citation Analysis]
15 Kaye S, Lokki AI, Hanttu A, Nissilä E, Heinonen S, Hakkarainen A, Lundbom J, Lundbom N, Saarinen L, Tynninen O, Muniandy M, Rissanen A, Kaprio J, Meri S, Pietiläinen KH. Upregulation of Early and Downregulation of Terminal Pathway Complement Genes in Subcutaneous Adipose Tissue and Adipocytes in Acquired Obesity. Front Immunol 2017;8:545. [PMID: 28559893 DOI: 10.3389/fimmu.2017.00545] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
16 Leone M, Einav S. Severe preeclampsia: what's new in intensive care? Intensive Care Med 2015;41:1343-6. [PMID: 25731635 DOI: 10.1007/s00134-015-3701-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
17 Small HY, Akehurst C, Sharafetdinova L, McBride MW, McClure JD, Robinson SW, Carty DM, Freeman DJ, Delles C. HLA gene expression is altered in whole blood and placenta from women who later developed preeclampsia. Physiol Genomics 2017;49:193-200. [PMID: 28130428 DOI: 10.1152/physiolgenomics.00106.2016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
18 Wu Y, Fu X, Wang L. Identification of novel biomarkers for preeclampsia on the basis of differential expression network analysis. Exp Ther Med 2016;12:201-7. [PMID: 27347039 DOI: 10.3892/etm.2016.3261] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
19 Amro FH, Moussa HN, Ashimi OA, Sibai BM. Treatment options for hypertension in pregnancy and puerperium. Expert Opinion on Drug Safety 2016;15:1635-42. [DOI: 10.1080/14740338.2016.1237500] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
20 Nair TM. Statistical and artificial neural network-based analysis to understand complexity and heterogeneity in preeclampsia. Comput Biol Chem 2018;75:222-30. [PMID: 29859381 DOI: 10.1016/j.compbiolchem.2018.05.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
21 Hong S, Banchereau R, Maslow BL, Guerra MM, Cardenas J, Baisch J, Branch DW, Porter TF, Sawitzke A, Laskin CA, Buyon JP, Merrill J, Sammaritano LR, Petri M, Gatewood E, Cepika AM, Ohouo M, Obermoser G, Anguiano E, Kim TW, Nulsen J, Nehar-Belaid D, Blankenship D, Turner J, Banchereau J, Salmon JE, Pascual V. Longitudinal profiling of human blood transcriptome in healthy and lupus pregnancy. J Exp Med 2019;216:1154-69. [PMID: 30962246 DOI: 10.1084/jem.20190185] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 9.3] [Reference Citation Analysis]
22 Eidem HR, Rinker DC, Ackerman WE 4th, Buhimschi IA, Buhimschi CS, Dunn-Fletcher C, Kallapur SG, Pavličev M, Muglia LJ, Abbot P, Rokas A. Comparing human and macaque placental transcriptomes to disentangle preterm birth pathology from gestational age effects. Placenta 2016;41:74-82. [PMID: 27208410 DOI: 10.1016/j.placenta.2016.03.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
23 Hall BM, Gleiberman AS, Strom E, Krasnov PA, Frescas D, Vujcic S, Leontieva OV, Antoch MP, Kogan V, Koman IE, Zhu Y, Tchkonia T, Kirkland JL, Chernova OB, Gudkov AV. Immune checkpoint protein VSIG4 as a biomarker of aging in murine adipose tissue. Aging Cell 2020;19:e13219. [PMID: 32856419 DOI: 10.1111/acel.13219] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]